Journal Papers, Abstracts, and Commentaries
| |
FULL-TEXT ARTICLE
Efficacy
of Six-Week Extended-Dose Nevirapine Varies by Infant Birth Weight with
Greatest Relative Efficacy in Low Birth Weight Infants.
Gupte N, Kinikar A, McIntire KN, et al
PLoS One.
2016 Sep 30;11(9):e0162979.
Paper
Randomized noninferiority trial of two maternal single-dose
nevirapine-sparing regimens to prevent perinatal HIV in Thailand
(PHPT-5).
Lallemant M, Le Coeur S, Sirirungsi W, et al
AIDS. 2015 Sep 13.
Abstract
Efficacy and Safety of an Extended Nevirapine Regimen in Infants of
Breastfeeding Mothers With HIV-1 Infection for Prevention of HIV-1
Transmission (HPTN 046): 18-Month Results of a Randomized, Double-Blind,
Placebo-Controlled Trial.
Fowler MG, Coovadia H, Herron CM, et al
J Acquir Immune Defic Syndr.
2014 Mar 1;65(3):366-74.
Abstract
Pooled Individual Data Analysis of Five Randomized Trials
of Infant Nevirapine Prophylaxis to Prevent Breast-Milk HIV-1
Transmission.
Hudgens MG, Taha TE, Omer SB, et
al
Clin Infect Dis.
2012 Sep 20
Abstract
Role of low-frequency HIV-1 variants in failure of
nevirapine-containing antiviral therapy in women
previously exposed to single-dose nevirapine.
Boltz VF, Zheng Y,
Lockman S, et al
Proc Natl Acad Sci U S A.
2011 May 31;108(22):9202-7.
Abstract
'Twelve-month follow-up of Six Week Extended Dose Nevirapine randomized
controlled trials:
differential impact of extended-dose nevirapine on mother-to-child transmission
and infant death
by maternal CD4 cell count.
Omer SB; for the Six Week Extended Dose Nevirapine (SWEN) Study Team.
AIDS. 2011 Feb 16
Abstract
Lack of effect from a previous single dose of nevirapine on virologic and
immunologic responses after 6 months
of antiretroviral regimens containing either efavirenz or lopinavir-ritonavir.
Dlamini JN, Hu Z, Somaroo H, Highbarger HC,
et al
Pharmacotherapy.
2011 Feb;31(2):158-63
Abstract
Independent effects of nevirapine prophylaxis and HIV-1 RNA suppression in
breast milk on
early perinatal HIV-1 transmission.
Chung MH, Kiarie JN, Richardson BA, et al
J Acquir Immune Defic Syndr. 2007 Dec 1;46(4):472-8
Abstract
|
Timing of maternal and neonatal dosing of nevirapine and the risk of
mother-to-child transmission
of HIV-1: HIVNET 024*
Chi BH, Wang L, Read JS, et al;
AIDS. 2005 Nov 4;19(16):1857-1864.
Abstract
Timing of the maternal drug dose and risk of perinatal HIV transmission in the
setting
of intrapartum and neonatal single-dose nevirapine.
Stringer JS, Sinkala M, Chapman V, et al.
AIDS. 2003 Jul 25;17(11):1659-1665.
Abstract
Comparison of Two Strategies for Administering Nevirapine
to Prevent Perinatal HIV
Transmission in High-Prevalence, Resource-Poor Settings.
Stringer JS, Sinkala M, Stout JP, et al.
J Acquir Immune Defic Syndr 2003 Apr 15;32(5):506-513
Abstract
Survival of Ugandan Infants with Subtype A and D HIV-1 Infection (HIVNET
012).
Eshleman SH, Guay LA, Fleming T, et al.
J Acquir Immune Defic Syndr 2002 Nov 1;31(3):327-30
Abstract
|
Impact
of human immunodeficiency virus type 1 (hiv-1) subtype on women
receiving
single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (hiv
network
for prevention trials 012 study).
Eshleman SH, Becker-Pergola G, Deseyve M, et al.
J Infect Dis 2001 Oct 1;184(7):914-917
Abstract
|
Impact of Human Immunodeficiency Virus Type 1 (HIV-1) Subtype on Women
Receiving
Single-Dose Nevirapine Prophylaxis to Prevent HIV-1 Vertical Transmission
Eshleman SH, Becker-Pergola G, Deseyve M, et al
J Infect Dis 2001 Aug 13;184(7)
Abstract
|
Nevirapine: a review of its use in the prevention and treatment of
paediatric
HIV infection.
Bardsley-Elliot A, Perry CM
Paediatr Drugs 2000 Sep-Oct;2(5):373-407
Abstract |
|
Journal Papers, Abstracts, and Commentaries
Journal Papers, Abstracts, and Commentaries
|
| |
Pooled Individual Data Analysis of Five Randomized Trials of
Infant Nevirapine Prophylaxis to Prevent Breast-Milk HIV-1 Transmission.
Hudgens MG, Taha TE, Omer SB, et al
Clin Infect Dis.
2012 Sep 20
Abstract
Effects of short-course zidovudine on the selection of
nevirapine-resistant HIV-1 in women taking single-dose nevirapine.
Micek MA, Blanco AJ, Carlsson J, et al
J Infect Dis.
2012 Apr 5.
Abstract
Addition of extended zidovudine to extended nevirapine prophylaxis reduces
nevirapine
resistance in infants who were HIV-infected in utero.
Lidström J, Li Q, Hoover DR, Kafulafula G,
et al
AIDS. 2010 Jan
28;24(3):381-6.
Abstract |
A randomized, double-blind, placebo-controlled trial of combined nevirapine
and zidovudine
compared with nevirapine alone in the prevention of perinatal transmission
of HIV in Zimbabwe.
Thistle P, Spitzer RF, Glazier RH, et al
Clin Infect Dis. 2007 Jan 1;44(1):111-9
Abstract
|
Intrapartum
and Neonatal Single-Dose Nevirapine Compared with
Zidovudine for
Prevention
of Mother-to-Child Transmission of HIV-1 in
Kampala, Uganda:
Randomized Trial
(HIVNET 012)
Guay LA, Musoke P, Fleming T, et al.
Lancet 1999 Sep
4;354(9181):795-802
Abstract
|
|
Journal Papers, Abstracts, and Commentaries
|
Journal Papers, Abstracts, and Commentaries
|
Journal Papers, Abstracts, and Commentaries
|
|
Nevirapine
Perinatal/Neonate Efficacy Data |
|
Monotherapy
National
Studies
Main
New/Newsworthy
Documents identified with this icon are in Portable Document Format (PDF)
and require the
Adobe
Acrobat Reader